Page last updated: 2024-10-20

pyridoxal phosphate and Nodding Syndrome

pyridoxal phosphate has been researched along with Nodding Syndrome in 1 studies

Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.

Nodding Syndrome: Unexplained neurologic condition characterized by episodes of atonic seizures, convulsions or staring spells with further cognitive decline.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dietmann, A1
Wallner, B1
König, R1
Friedrich, K1
Pfausler, B1
Deisenhammer, F1
Griesmacher, A1
Seger, C1
Matuja, W1
JilekAall, L1
Winkler, AS1
Schmutzhard, E1

Other Studies

1 other study available for pyridoxal phosphate and Nodding Syndrome

ArticleYear
Nodding syndrome in Tanzania may not be associated with circulating anti-NMDA-and anti-VGKC receptor antibodies or decreased pyridoxal phosphate serum levels-a pilot study.
    African health sciences, 2014, Volume: 14, Issue:2

    Topics: Adolescent; Adult; Aged; Autoantibodies; Case-Control Studies; Epilepsy; Female; Humans; Male; Middl

2014